Engineered Human iPSC-Derived Dendritic Cells Dressed with Tumor MHC Complexes As a Cancer Vaccine

Investigators presented an approach that involves differentiating universal major histocompatibility complex (MHC)-deficient hiPSCs into CCR7⁺ migratory dendritic cells.